Connect with us

Health

Some patients who see female doctors could live longer, study suggests: ‘Higher empathy’

Published

on

Some patients who see female doctors could live longer, study suggests: ‘Higher empathy’

Patients who are treated by a female physician could live longer and have a reduced risk of hospitalization, new research has found.

These benefits were seen more in female patients compared to males, according to the study, which was published in the peer-reviewed journal Annals of Internal Medicine.

“Among older adults hospitalized for a medical condition, mortality and readmission rates were lower for patients treated by female physicians than those cared for by male physicians — and the benefit of receiving treatment from female physicians was greater for female patients than for male patients,” lead study author Dr. Yusuke Tsugawa, associate professor-in-residence of medicine in the division of general internal medicine at the David Geffen School of Medicine at UCLA, told Fox News Digital.

PREGNANCY SPEEDS UP AGING PROCESS FOR YOUNG WOMEN, SAYS STUDY: ‘REMARKABLE FINDING’

The study included 700,000 Medicare beneficiaries 65 years of age and older who had been hospitalized between 2016 and 2019. 

Advertisement

The mortality rate was 8.15% for female patients treated by female physicians — compared to 8.38% for those treated by male physicians, according to a press release from UCLA Health.

Patients who are treated by a female physician could live longer and have a reduced risk of hospitalization, new research found. (iStock)

Dr. Shana Johnson, a physical medicine and rehabilitation physician in Scottsdale, Arizona, who was not involved in the research, noted that the findings are “clinically significant,” as the difference translates to an additional 1,053 female patient deaths.

Male patients also had lower mortality rates when treated by female physicians, but the difference was smaller.

Why the difference?

Dr. Marc Siegel, clinical professor of medicine at NYU Langone Medical Center and a Fox News medical contributor, was not involved in the study but called the findings “fascinating.”

Advertisement

“Women tend to have a higher empathy quotient, which can impact patient care and diagnosis and treatment directly,” he told Fox News Digital. 

“There has been a patriarchy in medicine for a long time, and there still may be some residual discounting of women’s health issues or [doctors] seeing them as emotionally based,” Siegel added.

ASK A DOC: ‘HOW CAN I GET RID OF A COLD SORE AS QUICKLY AS POSSIBLE?’

There is a “growing awareness” that doctors are more sensitive to health issues when they can relate directly to their patients, the doctor noted.

“This applies to screening, diagnosis and treatment,” he said. 

Advertisement

“Women tend to have a higher empathy quotient, which can impact patient care and diagnosis and treatment directly,” one doctor old Fox News Digital.  (iStock)

The findings were not surprising to the researchers, they said.

“Previous studies have shown that female patients treated by a female physician (versus female patients treated by a male physician) are less likely to experience underappreciation in symptom/illness severity assessment and communication challenges,” study co-author Atsushi Miyawaki, M.D., PhD, senior assistant professor in the Department of Health Services Research at the University of Tokyo, told Fox News Digital.

“Also, female physicians may help alleviate embarrassment, discomfort and sociocultural taboos during sensitive examinations and conversations [with] female patients,” he said.

“Mortality and readmission rates were lower for patients treated by female physicians than those cared for by male physicians.”

Advertisement

Other research has shown that female physicians are more likely to “adhere to clinical guidelines” and spend more time listening to patients compared to their male counterparts, which are “indicators of high-quality care,” added Tsugawa.

Johnson agreed, pointing out that prior studies have found male physicians may underestimate pain, gastrointestinal symptoms and heart symptoms when experienced by women. 

There is a “growing awareness” that doctors are more sensitive to health issues when they can relate directly to their patients, one medical professional said. (iStock)

“For instance, if a male and a female presented to the emergency room with upper stomach pain, the male would be checked for a heart attack and given medication for an upset stomach,” she told Fox News Digital.

“The woman, however, may only be given medication for an upset stomach.”

Advertisement

Study limitations

The study had some limitations, the researchers acknowledged.

“Due to limited clinical information available in our data, we could not identify the specific mechanisms underlying better outcomes for female patients treated by female physicians,” Tsugawa told Fox News Digital.

More research is needed to better understand the differences between female and male physicians, the researchers said. (iStock)

Miyawaki also noted that the study focused on older patients admitted to hospitals for medical conditions.

“Hence, our findings may not be generalizable to younger patients, commercially insured patients, those treated by other specialists or patients receiving care in an outpatient setting,” he told Fox News Digital.

Advertisement

“Individuals may focus on the importance of the doctor-patient relationship rather than on whether to choose a female doctor.”

More research is needed to better understand the differences between female and male physicians, Tsugawa said. 

“Those include guideline concordance and communication style, which lead to better patient outcomes for female physicians.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Johnson also noted that while the study is of “good quality,” there are “inherent limitations to the study design.”

Advertisement

She said, “With a retrospective review, unmeasured factors can affect and skew the results. The findings do align with other research in the area, however.”

The research suggests that increasing the number of female physicians could benefit women’s health overall, one of the study authors said. (iStock)

At the society level, Miyawaki said, the research suggests that increasing the number of female physicians could benefit women’s health.

“At the individual level, patient-physician interactions, rather than physician gender itself, are important for patient outcomes, our study suggests,” he said. 

Advertisement

“Thus, individuals may focus on the importance of the doctor-patient relationship rather than on whether to choose a female doctor.”

Tsugawa agreed, noting, “It is important to consider multiple factors about physicians, such as their clinical experience and training, your prior experiences with them, and their communication style, rather than focusing solely on the physician’s sex.”

For more Health articles, visit www.foxnews.com/health.

Health

New Wegovy pill offers needle-free weight loss — but may not work for everyone

Published

on

New Wegovy pill offers needle-free weight loss — but may not work for everyone

NEWYou can now listen to Fox News articles!

The first oral GLP-1 medication for weight loss has been approved for use in the U.S.

The Wegovy pill, from drugmaker Novo Nordisk, was cleared by the Food and Drug Administration to reduce excess body weight, maintain long-term weight reduction and lower the risk of major cardiovascular events.

Approval of the once-daily 25mg semaglutide pill was based on the results of two clinical trials — the OASIS trial program and the SELECT trial.

WEIGHT-LOSS DRUGS NOW LINKED TO CANCER PROTECTION IN WOMEN, MAJOR NEW STUDY REVEALS

Advertisement

The Wegovy pill demonstrated a mean weight loss of 16.6% in the OASIS 4 trial among adults who were obese or overweight and had one or more comorbidities (other medical conditions), according to a press release. In the same trial, one in three participants experienced 20% or greater weight loss.

The first oral GLP-1 medication for weight loss has been approved for use in the U.S. (iStock)

Novo Nordisk reported that the weight loss achieved with the pill is similar to that of injectable Wegovy and has a similar safety profile.

WEIGHT LOSS DRUGS COULD ADD YEARS TO AMERICANS’ LIVES, RESEARCHERS PROJECT

“With today’s approval of the Wegovy pill, patients will have a convenient, once-daily pill that can help them lose as much weight as the original Wegovy injection,” said Mike Doustdar, president and CEO of Novo Nordisk, in the press release.

Advertisement

Novo Nordisk reported that the weight loss achieved with the pill is similar to that of injectable Wegovy and has a similar safety profile. (James Manning/PA Images via Getty Images)

“As the first oral GLP-1 treatment for people living with overweight or obesity, the Wegovy pill provides patients with a new, convenient treatment option that can help patients start or continue their weight-loss journey.”

POPULAR WEIGHT-LOSS DRUGS COULD TAKE THE EDGE OFF YOUR ALCOHOL BUZZ, STUDY FINDS

The oral GLP-1 is expected to launch in the U.S. in early January 2026. Novo Nordisk has also submitted oral semaglutide for obesity to the European Medicines Agency (EMA) and other regulatory authorities.

“Most side effects will be GI-related and should be similar to the injectable, such as nausea, vomiting and constipation,” an expert said. (iStock)

Advertisement

Dr. Sue Decotiis, a medical weight-loss doctor in New York City, confirmed in an interview with Fox News Digital that studies show oral Wegovy is comparable to the weekly injectable, just without the needles.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Although the pill may result in better compliance and ease of use, Decotiis warned that some patients may not absorb the medication through the gastrointestinal tract as well as with the injectable version due to individual idiosyncrasies in the body.

“Most side effects will be GI-related and should be similar to the injectable, such as nausea, vomiting and constipation,” she said.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Advertisement

“In my practice, I have found tirzepatide (Mounjaro and Zepbound) to yield more weight loss and fat loss than semaglutide by about 20%,” the doctor added. “This has been shown in studies, often [with] fewer side effects.”

More oral GLP-1s may be coming in 2026, according to Decotiis, including an Orforglipron application by Lilly and a new combination Novo Nordisk drug, which is pending approval later next year.

One expert warned that some patients may not absorb the medication through the gastrointestinal tract as well as with the injectable version. (iStock)

“There will be more new drugs available in the future that will be more effective for patients who are more insulin-resistant and have not responded as well to semaglutide and/or tirzepatide,” the doctor said. “This is great news, as novel drugs affecting more receptors mean better long-term results in more patients.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

As these medications become cheaper and easier to access, Decotiis emphasized that keeping up with healthy lifestyle habits — including proper nutrition with sufficient protein and fiber, as well as increased hydration — is essential to ensuring lasting results.

CLICK HERE FOR MORE HEALTH STORIES

“If not, patients will regain weight and could lose muscle and not enough body fat,” she said.

Fox News Digital reached out to Novo Nordisk for comment.

Advertisement
Continue Reading

Health

Common household chemicals linked to increased risk of serious neurological condition

Published

on

Common household chemicals linked to increased risk of serious neurological condition

NEWYou can now listen to Fox News articles!

A study from Sweden’s Uppsala University discovered a link between microplastics and multiple sclerosis (MS).

The research, published in the journal Environmental International, discovered that exposure to two common environmental contaminants, PFAS and PCBs, could increase the risk of the autoimmune disease.

PFAS, or per- and polyfluoroalkyl substances, known as “forever chemicals,” are used in some common household products, such as non-stick cookware, textiles and cleaning products. They have also been found in drinking water throughout the U.S., according to the U.S. Environmental Protection Agency.

COMMON CLEANING CHEMICAL TIED TO SPIKE IN LIVER DISEASE ACROSS US, RESEARCHERS SAY

Advertisement

PCBs, or polychlorinated biphenyls, are toxic industrial chemicals once widely used in electrical equipment before being banned decades ago, as stated by the National Institute of Environmental Health Sciences.

The new study findings were based on blood samples of 1,800 Swedish individuals, including about 900 who had recently been diagnosed with MS, according to a university press release.

PFAS, or per- and polyfluoroalkyl substances, known as “forever chemicals,” are used in some common household products, including non-stick cookware. (iStock)

The first phase of the trial studied 14 different PFAS contaminants and three substances that appear when PCBs are broken down in the body. These were then investigated for a link to the odds of diagnosis.

‘FOREVER CHEMICALS’ FOUND IN US DRINKING WATER, MAP SHOWS ‘HOT SPOTS’ OF HIGHEST LEVELS

Advertisement

“We saw that several individual substances, such as PFOS and two hydroxylated PCBs, were linked to increased odds for MS,” lead study author Kim Kultima said in a statement. “People with the highest concentrations of PFOS and PCBs had approximately twice the odds of being diagnosed with MS, compared to those with the lowest concentrations.”

The researchers then examined the combined effects of these substances and found that the mixture was also linked to increased risk.

CLICK HERE FOR MORE HEALTH STORIES

Fellow researcher Aina Vaivade noted that risk assessments should consider chemical mixtures, not just individual exposures, because people are typically exposed to multiple substances at the same time.

“We saw that several individual substances, such as PFOS and two hydroxylated PCBs, were linked to increased odds for MS,” the lead study author said. (iStock)

Advertisement

The final phase of the study investigated the relationship between inheritance, chemical exposure and the odds of MS diagnosis, revealing that those who carry a certain gene variant actually have a reduced MS risk.

However, individuals who carried the gene and had higher exposure to PFOS a singular type of chemical in the PFAS family had an “unexpected” increased risk of MS.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“This indicates that there is a complex interaction between inheritance and environmental exposure linked to the odds of MS,” Kultima said. 

“We therefore think it is important to understand how environmental contaminants interact with hereditary factors, as this can provide new knowledge about the genesis of MS and could also be relevant for other diseases.”

Advertisement

Multiple sclerosis is a disease that leads to the breakdown of the protective covering of the nerves, according to Mayo Clinic. (iStock)

Fox News senior medical analyst Dr. Marc Siegel commented on these findings in an interview with Fox News Digital.

“MS is a complex disease that is somewhat autoimmune and somewhat post-inflammatory,” said Siegel, who was not involved in the study. “Epstein-Barr virus infection greatly increases the risk of MS.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

“There is every reason to believe that environmental triggers play a role, including microplastics, and this important study shows a correlation, but not causation — in other words, it doesn’t prove that the microplastics caused MS.”

Advertisement

The study had some limitations, the researchers acknowledged, including that the chemical exposure was measured only once, at the time of blood sampling. This means it may not accurately represent participants’ long-term or past exposure levels relevant to MS development.

“There is every reason to believe that environmental triggers play a role.”

Fox News Digital reached out to several industry groups and manufacturers requesting comment on the potential link between PFAS chemicals and multiple sclerosis. 

Several have issued public statements, including the American Chemistry Council, which states on its website that “manufacturers and many users of today’s PFAS are implementing a variety of practices and technologies to help minimize environmental emissions.”

In April 2024, the EPA enacted a new federal rule that sets mandatory limits on certain PFAS chemicals in drinking water, aiming to reduce exposure. The agency also aims to fund testing and treatment efforts.

Advertisement

A woman working out outdoors takes a sip of water from a plastic bottle. (iStock)

Multiple sclerosis is a disease that leads to the breakdown of the protective coverings that surround nerve fibers, according to Mayo Clinic.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The immune system’s attack on these nerve sheaths can cause numbness, weakness, trouble walking and moving, vision changes and other symptoms, and can lead to permanent damage.

There is currently no cure for MS, Mayo Clinic reports, but treatment is available to manage symptoms and modify the course of the disease.

Advertisement

Continue Reading

Health

Natural Ozempic? 6 GLP-1 Foods That Work Just Like the Shot

Published

on

Natural Ozempic? 6 GLP-1 Foods That Work Just Like the Shot


Advertisement


6 GLP-1 Foods That Boost Weight Loss Naturally—No Injections Needed | Woman’s World




















Advertisement











Advertisement




Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Trending